The AI engine Fit Assessment
BetaCapstan Therapeutics develops RNA-based therapies using targeted delivery systems to enhance treatments for oncology, fibrosis, and inflammation-related diseases.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
Capstan Therapeutics is now part of AbbVie.
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.